Cargando…

Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation

Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates...

Descripción completa

Detalles Bibliográficos
Autor principal: Erol, Adnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362849/
https://www.ncbi.nlm.nih.gov/pubmed/35958947
http://dx.doi.org/10.2147/CMAR.S373557
_version_ 1784764803670081536
author Erol, Adnan
author_facet Erol, Adnan
author_sort Erol, Adnan
collection PubMed
description Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates OTULIN at tyrosine 56, thereby disrupting its relationship with LUBAC. OTULIN-released LUBAC interacts with SPATA2 and is recruited to the TNF-R1sc, facilitating SPATA2-CYLD interaction. All these interactions are required for the activation of IKKβ to stimulate NF-κB transcriptional activity following genotoxic stress. IKKβ also induces the critical phosphorylation of CYLD at serine 568 to increase its deubiquitinating (DUB) activity required for the termination of signaling cascades. Contrary to the widespread belief that CYLD is an absolute tumor suppressor, CYLD initiates and terminates NF-κB activity by alternately using its oncoprotein and tumor suppressor activities, respectively. If IKKβ fails to achieve the DUB activity-inducing phosphorylation at serine 568, CYLD would operate in a sustained mode of oncogenic activity. The resulting dysregulated NF-κB activation and other accompanying pathologies will disrupt cellular homeostasis in favor of transformation.
format Online
Article
Text
id pubmed-9362849
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93628492022-08-10 Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation Erol, Adnan Cancer Manag Res Perspectives Oxidative stress, which can cause DNA damage, can both activate TNF-R1 directly in the absence of TNF stimulation and phosphorylate c-Abl, thus promoting its cytoplasmic translocation. Persistent cytoplasmic localization of c-Abl has been associated with cellular transformation. c-Abl phosphorylates OTULIN at tyrosine 56, thereby disrupting its relationship with LUBAC. OTULIN-released LUBAC interacts with SPATA2 and is recruited to the TNF-R1sc, facilitating SPATA2-CYLD interaction. All these interactions are required for the activation of IKKβ to stimulate NF-κB transcriptional activity following genotoxic stress. IKKβ also induces the critical phosphorylation of CYLD at serine 568 to increase its deubiquitinating (DUB) activity required for the termination of signaling cascades. Contrary to the widespread belief that CYLD is an absolute tumor suppressor, CYLD initiates and terminates NF-κB activity by alternately using its oncoprotein and tumor suppressor activities, respectively. If IKKβ fails to achieve the DUB activity-inducing phosphorylation at serine 568, CYLD would operate in a sustained mode of oncogenic activity. The resulting dysregulated NF-κB activation and other accompanying pathologies will disrupt cellular homeostasis in favor of transformation. Dove 2022-08-05 /pmc/articles/PMC9362849/ /pubmed/35958947 http://dx.doi.org/10.2147/CMAR.S373557 Text en © 2022 Erol. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Perspectives
Erol, Adnan
Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
title Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
title_full Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
title_fullStr Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
title_full_unstemmed Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
title_short Genotoxicity-Stimulated and CYLD-Driven Malignant Transformation
title_sort genotoxicity-stimulated and cyld-driven malignant transformation
topic Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362849/
https://www.ncbi.nlm.nih.gov/pubmed/35958947
http://dx.doi.org/10.2147/CMAR.S373557
work_keys_str_mv AT eroladnan genotoxicitystimulatedandcylddrivenmalignanttransformation